Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1997-08-11
1999-01-05
Raymond, Richard L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514212, 540451, 540463, 540480, 540481, 540482, 540485, 540526, 540527, 540528, 540529, 540530, 540531, 540596, 540597, 540598, 540602, 540604, 540605, 540606, 540607, 540608, 540609, 540610, A61K 3133, A61K 3155, C07D29500, C07D40500
Patent
active
058563180
ABSTRACT:
Certain nitrogen-containing cyclohetero cycloalkylaminoaryl compounds are described for treatment of CNS disorders such as cerebral ischemia, psychoses and convulsions. Compounds of particular interest are of the formula: ##STR1## wherein each of R.sup.1, R.sup.4, R.sup.5, R.sup.6 and R.sup.7 is independently selected from hydrido, lower alkyl, benzyl, and haloloweralkyl;
REFERENCES:
patent: 4204003 (1980-05-01), Szmuszkovicz
patent: 4463013 (1984-07-01), Collins et al.
patent: 4801604 (1989-01-01), Vonvoightlander et al.
Aram et al., J. Pharmacol. Exp. Ther., 248, 320-328 (1989) Abstract only.
Bailey et al., Eur. J. Pharmacol., 240, 243-250 (1993).
Canoll et al., J. Neurosci. Res., 24, 311-328 (1989) Abstract only.
Carter et al., J. Pharm. Exp. Ther., 247(3), 1222-1232 (1988).
Clissold et al., J. Pharmacol. Exp. Ther., 265, 876-886 (1993).
Contreras et al., Brain Res., 546, 79-82 (1991).
Cook et al., J. Pharmacol. Exp. Ther., 263, 1159-1166 (1992) Abstract only.
De Costa et al., Febs. Letters, 251, 53-58 (1989).
De Costa et al., J. Med. Chem., 32(8), 1996-2002 (1989).
De Costa et al., J. Med. Chem., 35(1), 38-47 (1992).
De Costa et al., J. Med. Chem., 35(23), 4334-4343 (1992).
DeCoster et al., Brain Res., 671, 45-53 (1995) Abstract only.
DeHaven-Hudkins et al., Life Sci., 56, 1571-1576 (1995).
Gerwitz et al., Neuropsychopharmacology, 10, 37-40 (1994).
Gilman et al., The Pharmacological Basis of Therapeutics, 7.sup.th ed., 404, MacMillan (1985).
Itzhak et al., FASEB J., 3, 1868-1872 (1989).
Kirk et al., J. Pharmacol. Exp. Ther., 271, 1080-1085 (1994) Abstract only.
Klein et al., J. Pharmacol. Exp. Ther., 260, 990-999 (1992) Abstract only.
Klein et al., Eur. J. Pharmacol., 254, 239-248 (1994).
Lesage et al., Synapse, 20, 156-64 (1995) Abstract only.
Lason et al., Brain Res., 482, 333-339 (1989).
Long et al., Soc. Neurosci Abs., 16, 1122, abs 461.4 (1990).
Loscher et al., Eur. J. Pharmacol., 238, 191-200 (1993).
Lysko et al., Stroke, 23, 414-419 (1992) Abstract only.
Lysko et al., Stroke, 23, 1319-1323 (1992) Abstract only.
Parsons et al., Neuropharm., 25(2), 217-220 (1986).
Pontecorvo et al., Brain Res. Bull., 26, 461-465 (1991) Abstract only.
Radesca et al., J. Med. Chem., 34(10), 3058-3065 (1991).
Reddy et al., J. Med. Chem., 37, 260-267 (1994) Abstract only.
Roth et al., Eur. J. Pharmacol., 236, 327-331 (1993).
Rothman et al., Annals of Neurology, 19(2), 105-111 (1986).
Scopes et al., J. Med. Chem., 35, 490-501 (1992).
Takahashi et al., Stroke, 26, 1676-1682 (1995) Abstract only.
Tam in Sigma Receptors, Y. Itzhak ed., Academic Press, Harcourt Brace & Co. Publishers London (1994) ISBN 0-12-376350-9.
Tortella et al., Trends Pharmacol. Sci., 10:501-507 (1990).
Tortella et al., Trends Pharmacol. Sci., 11:146-147 (1990).
Weissman et al., Biol. Psych., 29, 41-54 (1991).
Witkin et al., J. Pharmacol. Exp. Ther., 266, 473-482 (1993).
Derwent Abstract of WO/9212128.
Bowen Wayne
de Costa Brian R.
Dominguez Celia
He Xiao-Shu
Rice Kenner C.
Kifle Bruck
Raymond Richard L.
The United States of America as represented by the Department of
LandOfFree
Nitrogen-containing cyclohetero cyclo-heteroaminoaryl derivative does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nitrogen-containing cyclohetero cyclo-heteroaminoaryl derivative, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nitrogen-containing cyclohetero cyclo-heteroaminoaryl derivative will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-862463